Evidence map›Paper›PMID 35023323›Full record

ReviewWIREs mechanisms of disease2022

Orexin, serotonin, and energy balance.

Vijayakumar Mavanji, Brianna Pomonis, Catherine M Kotz

Open access · hybridAbstract readReview
In one paragraph

Review in WIREs mechanisms of disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Metabolic Brain Disorders: Prodromes, Symptoms, and Syndromes.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Vijayakumar MavanjiResearch Service, Minneapolis VA Health Care System, Minneapolis, Minnesota, USA.ORCID 0000-0001-8032-2242
Brianna PomonisResearch Service, Minneapolis VA Health Care System, Minneapolis, Minnesota, USA.
Catherine M KotzDepartment of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-0051-3159
Minneapolis VA Health Care System · USUniversity of Minnesota · US

Funding

Rescue of dormant brain circuits in neurodegenerative diseaseI01BX003004 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI BILLINGTON, CHARLES J., KOTZ, CATHERINE M · 2016 to 2019
–
Orexin and serotonin interactions to promote physical activity and prevent obesityI01BX003687 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI BILLINGTON, CHARLES J., KOTZ, CATHERINE M · 2018 to 2022
–
BLRD VA I01 BX003004BLRD VA I01 BX003687
6 · The paper itself

Abstract

The lateral hypothalamus is critical for the control of ingestive behavior and spontaneous physical activity (SPA), as lesion or stimulation of this region alters these behaviors. Evidence points to lateral hypothalamic orexin neurons as modulators of feeding and SPA. These neurons affect a broad range of systems, and project to multiple brain regions such as the dorsal raphe nucleus, which contains serotoninergic neurons (DRN) important to energy homeostasis. Physical activity is comprised of intentional exercise and SPA. These are opposite ends of a continuum of physical activity intensity and structure. Non-goal-oriented behaviors, such as fidgeting, standing, and ambulating, constitute SPA in humans, and reflect a propensity for activity separate from intentional activity, such as high-intensity voluntary exercise. In animals, SPA is activity not influenced by rewards such as food or a running wheel. Spontaneous physical activity in humans and animals burns calories and could theoretically be manipulated pharmacologically to expend calories and protect against obesity. The DRN neurons receive orexin inputs, and project heavily onto cortical and subcortical areas involved in movement, feeding and energy expenditure (EE). This review discusses the function of hypothalamic orexin in energy-homeostasis, the interaction with DRN serotonin neurons, and the role of this orexin-serotonin axis in regulating food intake, SPA, and EE. In addition, we discuss possible brain areas involved in orexin-serotonin cross-talk; the role of serotonin receptors, transporters and uptake-inhibitors in the pathogenesis and treatment of obesity; animal models of obesity with impaired serotonin-function; single-nucleotide polymorphisms in the serotonin system and obesity; and future directions in the orexin-serotonin field. This article is categorized under: Metabolic Diseases > Molecular and Cellular Physiology.

Indexed as

Energy MetabolismSerotoninAnimalsHumansHypothalamic Area, LateralHypothalamusOrexinsOrexinsSerotoninenergy expenditureorexinphysical activityserotonin

Identifiers

PMID35023323
PMCPMC9286346
OpenAlexW3200900020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.